Updates are available Correction dated 2023-05-16
Click to view Correction: https://doi.org/10.1007/s10856-023-06722-6
-
Authors
Rahimi, Behnaz
Behroozi, Zahra
Motamednezhad, Ali
Jafarpour, Maral
Hamblin, Michael R.
Moshiri, Ali
Janzadeh, Atousa
Ramezani, Fatemeh
-
Funding
Funding for this research was provided by:
iran university of medical sciences (97-4-32-13632)
- License Information
-
More Information
Article History
Received: 19 July 2022
Accepted: 15 January 2023
First Online: 21 February 2023
Change Date: 16 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10856-023-06722-6
Compliance with ethical standards
:
: MRH declares the following potential conflicts of interest. Scientific Advisory Boards: Transdermal Cap Inc, Cleveland, OH; Hologenix Inc. Santa Monica, CA; Vielight, Toronto, Canada; JOOVV Inc, Minneapolis-St. Paul MN; Sunlighten, Kansas City, MO; Consulting; USHIO Corp, Japan; Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany. Stockholding: Niraxx Light Therapeutics, Inc, Irvine CA; JelikaLite Corp, New York NY. The other authors declare no conflict of interest.
: This proposal was approved in IRAN University of Medical Sciences ethics approval center with cod number IR.IUMS.REC.1398.318.
